Maze Therapeutics MAZE
NASDAQ MAZE
$35.45 +0.54 (+1.55%)
At close: Nov 10, 2026 · 4:00 PM EST

Maze Therapeutics (MAZE) Other Non-Current Liabilities (2024 - 2026)

Updated

Maze Therapeutics (MAZE) recorded Other Non-Current Liabilities of $388,000 in Q1 2026, down 61.4% from $1.01 million a year earlier and down 64.5% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics reported Other Non-Current Liabilities of $1.09 million, up 12.9% from FY2024.

  • Across earlier years, Other Non-Current Liabilities came in at $969,000 in FY2024.
  • Per Business Quant, the preceding three quarters came in at $1.09 million (Q4 2025), $1.09 million (Q3 2025) and $1.09 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Maze Therapeutics 2.05 Bn 561.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 388,000.00
Dec 31, 2025 1.09 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 969,000.00
API Access

Maze Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MAZE&period=max&api_key=YOUR_API_KEY